CPT Code 45388 Complete Billing & Coding Guide for Colonoscopy with Ablation

CPT 45388 describes a flexible colonoscopy with ablation of tumor(s), polyp(s), or other lesion(s) using techniques such as cautery, laser, argon plasma coagulation (APC), or other non-excisional destruction methods.

It is a therapeutic code for colonoscopy when destruction of the lesion is performed in place instead of removal. This procedure is frequently used for flat lesions, vascular abnormalities and for the remaining tissue that is not appropriate for snare or biopsy techniques.

CPT 45388 is a well-established code in gastroenterology, but is often misreported because of confusion with the other codes for polypectomy (45385), biopsy (45380) and hot biopsy forceps (45384) and thus bundled and claim denial. 

Correct coding requires correct identification of the ablation technique, type of lesion and procedural intent. 

CPT 45388 – Description

Official Definition:

“Colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed).”

This procedure includes:

• Flexible colonoscope insertion and full colon examination (typically to cecum or proximal colon)
• Ablation or destruction of lesions using energy-based techniques
• Methods may include argon plasma coagulation (APC), laser, or other thermal modalities
• Pre- and post-dilation and guidewire passage when performed are included

Key clarifications:

• Ablation = CPT 45388
• Snare removal = CPT 45385
• Hot biopsy forceps removal = CPT 45384
• Biopsy only = CPT 45380
• Diagnostic colonoscopy is always bundled

Clinical Indications (When CPT 45388 Is Used)

CPT 45388 is used when lesions require destruction rather than excision.

Common indications include:

• Flat or sessile colorectal lesions not suitable for snare removal
• Residual polyp tissue due to incomplete resection.
• Angiodysplasia or vascular malformations treatment (APC treatment).
• The lesions that bleed will need thermal coagulation.
• Small tumors or dysplastic regions that need to be ablated.
• Surveillance for colorectal lesions that have been treated
• Intervention during screening colonoscopy conversion 

In most cases, CPT 45388 is used when lesion destruction is preferred over physical removal due to anatomy, bleeding risk, or lesion type.

Reimbursement Insights For CPT Code 45388

The reimbursement for CPT code 45388 depends on the payer, setting, and procedural complexity. 

• In lower facility settings, professional fees are typically lower, as they often include technical aspects of care.
• Non-facility settings consist of higher practice expense RVUs
• Payer rates for commercial payers are contract specific and generally are higher than Medicare rates.
• Medicare uses the Physician Fee Schedule (PFS) geographic adjustments
• Global period: 000 (no days of postoperative period)
• The selection of a screening to therapeutic conversion has a significant effect on reimbursement and patient cost sharing. 

Applicable Modifiers For CPT Code 45388

The proper use of modifiers is crucial to ensuring that CPT 45388 is utilized correctly and that reimbursements are accurate. 

• -PT (Medicare): Used when a screening colonoscopy converts into therapeutic procedure due to ablation
• -33 (Preventive Services): Used for commercial/Medicaid preventive intent when ablation is performed
• -59 / X{EPSU}: Used when different techniques are performed on separate lesions (e.g., ablation + snare)
• -22 (Increased Procedural Services): Applies to complex ablations that take more effort from the physician and more support of documentation. 
• -52 (Reduced Services): Used when the procedure is partially completed, depending on payer rules
• -53 (Discontinued Procedure): Used when the procedure is terminated due to medical or technical reasons

All modifier use must be supported with detailed operative documentation.

Documentation Requirements For CPT Code 45388

Documentation is key to CPT 45388 reimbursement and compliance. 

Key documentation elements include:

• Indication (screening, diagnostic, or therapeutic)
• Extent of colon examined
• The type, size and location of the lesions
• Description of the ablation technique: APC, laser, etc.
• Energy level and treatment parameters (if any)
• Complete or partial ablation confirmed. 
• Bowel preparation quality
• Complications or procedural limitations
• Tissue obtained elsewhere and correlated with pathology
• Final signed physician report. 

CPT Code 45388 - Example Clinical Scenarios

Scenario 1: Ablation of Angiodysplasia

A patient presents with occult GI bleeding. Colonoscopy reveals angiodysplasia in the ascending colon, treated using argon plasma coagulation.

→ Coding Outcome: CPT 45388

→ Rationale: Ablation of vascular lesions using thermal energy.

Scenario 2: Flat Lesion Treated with Ablation

A flat sessile lesion is identified during colonoscopy and destroyed using laser ablation.

→ Coding Outcome: CPT 45388

→ Rationale: Lesion treated using non-excisional ablation technique.

Scenario 3: Screening Converted to Ablation

A screening colonoscopy is performed. A small vascular lesion is identified and treated with APC.

→ Coding Outcome: CPT 45388 with modifier -PT

→ Rationale: Screening converted into therapeutic procedure.

Scenario 4: Mixed Techniques in Same Session

A snare polypectomy is performed on one lesion and ablation is performed on another lesion.

→ Coding Outcome:

• CPT 45385 (primary procedure)
• CPT 45388 with modifier -59/X (if distinct and supported)

→ Rationale: Different techniques performed on separate lesions.

BillingFreedom Known For Gastroenterology Medical Billing Built on High-Performance Revenue Cycle Standards

At BillingFreedom, our gastroenterology medical billing and coding framework is built on a performance-driven revenue cycle model designed specifically for high-volume endoscopy practices, including CPT 45388 and related colonoscopy procedures.

We have a structured coding confirmation and denial prevention system that provides the highest possible first pass claim acceptance (97%-99%) and meets CMS, MAC and commercial payer guidelines. 

We operate on a layered compliance model that combines clinical coding accuracy, modifier validation, and payer-specific rule enforcement to reduce financial leakage in colonoscopy-heavy workflows.

Core Performance Metrics Observed Across GI Billing Operations

• First-pass claim: 97% – 99%  acceptance rate
• Average denial rate: below 1%
• Clean claim: 95%+ submission rate
• Average A/R cycle time: 18–28 days
• Up to 15% – 25% improvement in revenue recovery with correction of undercoding and modifier errors 
• Coding accuracy rate after internal QA review: 98%+

Operational Impact on Gastroenterology Practices

Through this structured model, gastroenterology healthcare service providers working with BillingFreedom typically experience:

• Faster reimbursement cycles with less claim rework. 
• Increased net collections from correction of coding leakage. 
• Reduce denials due to complex therapeutic colonoscopy procedures 
• Improved payer compliance stability across Medicare and commercial contracts
• Simplified administrative processes for billing personnel 
• Improved audit readiness through documentation alignment checks 

All billing workflows are in sync with CMS policies, AMA CPT and Payer LCD policies. The system will maximize the accuracy of reimbursements while keeping the compliance and audit risk exposure to a minimum. 

For more details about our exceptional Gastroenterology medical billing services, please don't hesitate to contact us  via email at info@billingfreedom.com or call us at +1 (855) 415-3472. 

Financial peace of mind is our goal!